PG
DXCM icon

PEAK6 Group’s DexCom DXCM Stock Holding History

PEAK6 Group’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-234,000
Closed -$2.86M – 4241
2017
Q3 		$2.86M Buy
234,000
+162,400
+227% +$2.87M 0.01% 1112
2017
Q2 		$1.31M Buy
71,600
+26,000
+57% +$480K 0.01% 1703
2017
Q1 		$966K Sell
45,600
-9,600
-17% -$187K 0.01% 1715
2016
Q4 		$824K Buy
55,200
+20,800
+60% +$368K 0.01% 2048
2016
Q3 		$754K Sell
34,400
-1,600
-4% -$35.6K 0.01% 2018
2016
Q2 		$714K Buy
36,000
+22,400
+165% +$381K 0.01% 2070
2016
Q1 		$231K Sell
13,600
-56,000
-80% -$935K ﹤0.01% 3000
2015
Q4 		$1.43M Sell
69,600
-641,600
-90% -$13.4M 0.01% 1621
2015
Q3 		$15.3M Buy
711,200
+164,400
+30% +$3.67M 0.08% 299
2015
Q2 		$10.9M Buy
546,800
+204,000
+60% +$3.58M 0.07% 389
2015
Q1 		$5.34M Buy
342,800
+284,000
+483% +$4.29M 0.04% 644
2014
Q4 		$809K Buy
+58,800
New +$720K 0.01% 2138

Other funds holding DXCM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

PEAK6 Group's DXCM Position: Q4 2017 in Review

PEAK6 Group sold out of DexCom (DXCM) in Q4 2017, closing a stake of 232,412 shares — an estimated $2.84M sold.

PEAK6 Group first reported a position in DXCM in Q1 2014 and held it in 9 quarters. The position peaked at $4.85M in Q3 2015. 273 funds tracked by Wall St. Rank hold DXCM as of Q4 2017.

  • PEAK6 Group reported no remaining DexCom position as of Q4 2017 after selling out during the quarter.
  • PEAK6 Group sold 232,412 DexCom shares in Q4 2017, an estimated $2.84M.
  • PEAK6 Group first reported a position in DexCom in Q1 2014 and held it in 9 quarters.
  • PEAK6 Group's DexCom position peaked at $4.85M in Q3 2015.
  • 273 funds tracked by Wall St. Rank held DexCom as of Q4 2017.

Based on PEAK6 Group's 13F filing for Q4 2017, filed 14 Feb 2018.